PMC:7408073 / 101488-103319
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T9 | 830-834 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
T10 | 868-872 | Body_part | denotes | hand | http://purl.org/sig/ont/fma/fma9712 |
T11 | 1252-1257 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T12 | 1258-1262 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T13 | 1263-1268 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
T14 | 1269-1278 | Body_part | denotes | intestine | http://purl.org/sig/ont/fma/fma7199 |
T15 | 1279-1285 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
T16 | 1286-1299 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
T17 | 1300-1305 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T18 | 1447-1452 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T19 | 1543-1549 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T20 | 1694-1698 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T200 | 337-340 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
T201 | 830-834 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
T202 | 868-872 | Body_part | denotes | hand | http://purl.obolibrary.org/obo/UBERON_0002398 |
T203 | 1252-1257 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T204 | 1258-1262 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T205 | 1263-1268 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
T206 | 1269-1278 | Body_part | denotes | intestine | http://purl.obolibrary.org/obo/UBERON_0000160 |
T207 | 1279-1285 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T208 | 1286-1299 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
T209 | 1300-1305 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T210 | 1447-1452 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T211 | 1694-1698 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3528 | 421-424 | Gene | denotes | ACE | Gene:59272 |
3529 | 425-429 | Gene | denotes | ACE2 | Gene:59272 |
3530 | 449-452 | Gene | denotes | ACE | Gene:59272 |
3531 | 511-515 | Gene | denotes | ACE2 | Gene:59272 |
3532 | 1195-1199 | Gene | denotes | ACE2 | Gene:59272 |
3533 | 1360-1364 | Gene | denotes | ACE2 | Gene:59272 |
3534 | 1605-1609 | Gene | denotes | ACE2 | Gene:59272 |
3535 | 1003-1006 | Gene | denotes | MLN | Gene:4295 |
3536 | 691-694 | Gene | denotes | MLN | Gene:4295 |
3537 | 20-23 | Gene | denotes | MLN | Gene:4295 |
3538 | 204-212 | Species | denotes | patients | Tax:9606 |
3539 | 629-637 | Species | denotes | patients | Tax:9606 |
3540 | 1166-1174 | Species | denotes | patients | Tax:9606 |
3541 | 1425-1433 | Species | denotes | patients | Tax:9606 |
3542 | 1537-1542 | Species | denotes | human | Tax:9606 |
3543 | 1646-1654 | Species | denotes | patients | Tax:9606 |
3544 | 1813-1820 | Species | denotes | patient | Tax:9606 |
3545 | 300-318 | Disease | denotes | hypoxic conditions | MESH:D000071069 |
3546 | 620-628 | Disease | denotes | COVID-19 | MESH:C000657245 |
3547 | 1416-1424 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T561 | 620-628 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T562 | 1416-1424 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T15 | 216-217 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T16 | 325-329 | http://www.ebi.ac.uk/efo/EFO_0001410 | denotes | arms |
T17 | 372-373 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T18 | 526-534 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T19 | 805-813 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | actively |
T20 | 830-834 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
T21 | 950-952 | http://purl.obolibrary.org/obo/CLO_0050475 | denotes | my |
T22 | 1184-1185 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T23 | 1252-1257 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T24 | 1252-1257 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T25 | 1252-1257 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T26 | 1252-1257 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T27 | 1258-1262 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T28 | 1258-1262 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T29 | 1263-1268 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T30 | 1263-1268 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
T31 | 1269-1278 | http://purl.obolibrary.org/obo/UBERON_0000160 | denotes | intestine |
T32 | 1269-1278 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | intestine |
T33 | 1279-1285 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T34 | 1279-1285 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T35 | 1279-1285 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
T36 | 1286-1299 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
T37 | 1300-1305 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T38 | 1300-1305 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T39 | 1447-1452 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T40 | 1447-1452 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T41 | 1478-1486 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T42 | 1525-1533 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T43 | 1537-1542 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T44 | 1543-1549 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T45 | 1588-1591 | http://purl.obolibrary.org/obo/CLO_0001046 | denotes | 116 |
T46 | 1610-1620 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T47 | 1675-1683 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T48 | 1694-1698 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
T49 | 1742-1743 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T57445 | 337-340 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
T42648 | 795-803 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
T66997 | 878-882 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T55490 | 1577-1586 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 1300-1317 | http://purl.obolibrary.org/obo/GO_0007596 | denotes | blood/coagulation |
T4 | 1306-1317 | http://purl.obolibrary.org/obo/GO_0050817 | denotes | coagulation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T494 | 0-115 | Sentence | denotes | Different routes of MLN-4760 treatment administration can be pursued depending on the hospital condition/expertise. |
T495 | 116-278 | Sentence | denotes | In this exceptionally critical situation, it could be delivered to critical untreatable patients as a controlled “compassionate use”, in particular by inhalation. |
T496 | 279-478 | Sentence | denotes | However, when, under hypoxic conditions, both arms of the RAS are upregulated, it might have a limited action and, by shifting the balance of ACE/ACE2 ratio in favour of ACE, might be even dangerous. |
T497 | 479-690 | Sentence | denotes | Instead, specific inhibition of ACE2 enzymatic activity might effectively work in preventing the establishment of positive feedback loops in COVID-19 patients who are suffering from mild symptoms of the disease. |
T498 | 691-854 | Sentence | denotes | MLN-4760 is sold by different companies, that, in case it works, could be encouraged to manufacture the molecule, actively contributing to face this global threat. |
T499 | 855-1002 | Sentence | denotes | On the other hand, the drug could be also synthesized in University chemistry labs because, to my knowledge, is no longer under patent restriction. |
T500 | 1003-1434 | Sentence | denotes | MLN-4760, whose clinical development was abandoned after phase I trials (clinical name, ORE1001), is actually an interesting compound that could be useful for all patients in which a specific ACE2 upregulation is proven and associated to different (heart/lung/liver/intestine/kidney/immune system/blood/coagulation, etc.) pathological conditions related to ACE2 pathway downstream events, as it seems to occur in COVID-19 patients. |
T501 | 1435-1831 | Sentence | denotes | Although in blood of normal subjects sACE2 activity is undetectable because its catalytic activity in human plasma is masked by an endogenous inhibitor [116] and chronic ACE2 activation may be deleterious, some patients might need of sACE2 activity to better face an acute pathological condition, therefore a careful monitoring of clinical parameters should be performed during patient treatment. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32708755-18223027-20679036 | 1588-1591 | 18223027 | denotes | 116 |